This inventor holds 3 USPTO granted patents. Top assignee: Schwarz Pharma Ag. Active years: 1994-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dusseldorf, DE (1994)
- Erkrath, DE (1997 - 1998)
Company Filing History:
Years Active: 1994-1998
Title: Martin Feelisch: Innovator Promoting Cardiovascular Health
Introduction:
Meet Martin Feelisch, a remarkable innovator and inventor from Erkrath, Germany, whose passion for improving cardiovascular health has driven him to develop groundbreaking patents. With a strong background in pharmaceutical research, Martin has made significant contributions to the medical field through his innovative ideas and inventive spirit.
Latest Patents:
Martin Feelisch has a remarkable track record of three patented inventions, all aimed at advancing treatments and preventive measures related to cardiovascular health. His latest patents include:
1. Transdermal presentation of nitroglycerin for preventing undesired labor: This patent explores a novel method of delivering nitroglycerin to prevent premature labor. By utilizing a transdermal delivery system, Martin's innovation aims to enhance the efficiency and effectiveness of this medical intervention.
2. Organic nitrates containing a disulfide group as cardiovascular agents: This patent focuses on the development of organic nitrates containing a disulfide group as potential cardiovascular agents. These agents could have significant implications in treating various cardiovascular conditions.
Career Highlights:
Martin Feelisch is currently associated with Schwarz Pharma AG, a renowned pharmaceutical company known for its innovative research and development in the healthcare sector. His affiliation with Schwarz Pharma AG highlights his dedication to pushing the boundaries of medical science and improving patient outcomes.
Collaborations:
Throughout his career, Martin has collaborated with notable individuals in the field of pharmaceutical research. Among his coworkers, Klaus Sandrock and Eike Noack are renowned researchers who have worked closely with Martin in his pursuit of innovative solutions to cardiovascular health challenges. Such collaborative efforts further underscore Martin's commitment to the collective advancement of medical knowledge and patient care.
Conclusion:
Martin Feelisch's impressive portfolio of patents and collaborations highlights his steadfast commitment to innovative solutions in the field of cardiovascular health. His unwavering dedication to improving patient outcomes has made him a valuable asset to Schwarz Pharma AG and the broader scientific community. As Martin continues to forge ahead, his inventions are likely to have a lasting impact on the development of new treatments and preventive measures in cardiovascular medicine.
For more information about Martin Feelisch and other notable inventors, please visit our website idiyas.com.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile